Pyruvate carboxylase deficiency: A benign variant with normal development

49Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The devastating nature of a pyruvate carboxylase deficiency is underscored by the uniformly fatal outcome of the neonatal (French) type and the severely disabling and ultimately fatal outcome of the infantile (North American) type. We report a 7-y-oId girl with metabolic and biochemical features of the North American phenotype. Remarkably, the clinical course has been benign with preservations of motor and mental abilities. The residual enzyme activity in cultured skin fibroblast homog-enates was 1.8% and cross-reacting material was present in normal abundance and electrophoretic mobility. She has had several episodes of metabolic acidosis with elevated lactate, pyruvate, alanine, β-hydroxybutyrate, acetoace-tate, lysine, and proline values, and undetectably low aspartate concentrations. These crises have been managed by rehydration and bicarbonate therapy. We are unable to provide a satisfactory explanation for the uniquely benign clinical course that has been experienced by this patient. © 1991 International Pediatric Research Foundation, Inc.

Cite

CITATION STYLE

APA

Van Coster, R. N., Fernhoff, P. M., & De Vivo, D. C. (1991). Pyruvate carboxylase deficiency: A benign variant with normal development. Pediatric Research, 30(1), 1–4. https://doi.org/10.1203/00006450-199107000-00001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free